United States: Roundtable Discussion Results In Senate Committee White Paper On Stark Law Reform

Summary

On June 30, 2016, the US Senate Committee on Finance released a white paper titled Why Stark, Why Now? Suggestions to Improve the Stark Law to Encourage Innovative Payment Models, that addressed suggestions for reform of the federal physician self-referral or Stark law. The white paper summarizes comments and recommendations gathered during a roundtable discussion held by the Senate Finance Committee and the US House Committee on Ways and Means in December 2015 as well as written comments submitted by roundtable participants and other stakeholders in the weeks following the meeting.

In Depth

On June 30, 2016, the US Senate Committee on Finance (Committee) released a white paper titled Why Stark, Why Now? Suggestions to Improve the Stark Law to Encourage Innovative Payment Models, that addressed suggestions for reform of the federal physician self-referral or Stark law (the Stark Law) (42 U.S.C. § 1395nn). The white paper summarizes comments and recommendations gathered during a roundtable discussion held by the Senate Finance Committee and the US House Committee on Ways and Means in December 2015 as well as written comments submitted by roundtable participants and other stakeholders on topics taken up by the roundtable in the weeks following the meeting. The stated purpose of the roundtable discussion and written comments was to gather perspectives on an array of "known issues" including the current Stark Law environment, implications of the Stark Law for health care reform implementation, costs associated with compliance and disclosures, possible fixes under both fee for service (FFS) and alternative payment models, and CMS's limited authority to create exceptions and to issue advisory opinions. Stakeholders were asked to focus their written comments on (1) changes to the Stark law needed to implement health care reform, specifically the alternative payment models (APMs) contemplated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), and (2) the distinction between technical and substantive Stark Law violations.

Senate Finance Committee Chairman Senator Orrin Hatch commented in a press release that "[t]he health care industry has changed significantly since Stark was first implemented, and while the original goals of the Stark law were appropriate, today it is presenting a real burden for hospitals and doctors trying to find new ways to provide high quality care while reducing costs as they work to implement recent health care reforms. . . [The] paper reflects critical feedback from the stakeholder community on the law's ambiguities, its unintended consequences and the need for reform, and I am hopeful it jumpstarts the discussion on how Congress can modernize the law to make it work for patients, providers, and taxpayers." Provided below is a summary of the recommendations and comments received during the process and reported in the white paper, which presents many variations on the themes outlined below.

Identifying a Need for Reform

While the bulk of the white paper is a recitation of the recommendations expressed during the roundtable and written comments, the Committee provides valuable context regarding the Stark Law's background and the current need for reform. The impetus for change comes both from the current complexity of the Stark Law and the changing reimbursement landscape. The Committee notes that while "Congress intended the Stark law to provide a bright line test to curb physician self-referral. . . the Stark law's breadth, complexity, and impenetrability have created a minefield for the health care industry." Additionally, the Committee notes that the Stark Law has become "unnecessary for, and a significant impediment to value-based payment models." Specifically, while Congress has implemented some revisions to the Stark Law to facilitate APMs (e.g., providing the ability for HHS to issue regulatory waivers from the Stark Law for certain innovative payment and service delivery models under the Affordable Care Act), the Stark Law "continues to pose significant risks for implementation of such programs. Importantly, commenters noted, Medicare waivers do not clearly protect all alternative payment models under MACRA or with commercial payers, undercutting hospitals' ability to provide uniform and consistent incentives for physicians across all patient populations."

Supporting Alternative Payment Models

Commenters proposed a range of approaches that Congress and CMS may take to support health care reforms that implement APMs and were asked to also provide suggestions that would work in a FFS payment environment as well.

Some commenters advocated repealing all or part of the Stark Law. Others advocated only the repeal of the law's application to compensation arrangements or otherwise modifying how the Stark Law treats compensation arrangements. Recommendations included changing the fair market value requirement for compensation arrangements to accommodate APMs and the adoption of a special rule that would deem compensation arrangements promoting MACRA-based APMs to be fair market value and not take into account the volume or value of referrals, both key elements of the law's personal services exception. (42 USCS § 1395nn(e)(3) and 42 C.F.R. § 411.357(d).)

Comments also focused on the modification or expansion of existing waivers and exceptions to the Stark Law or creation of new waivers and exceptions, including the following: (1) implementation of new waivers contingent on satisfying risk assumption and/or other criteria; (2) expansion of the current Medicare Shared Savings Program (MSSP) waivers to qualifying APMs or the creation of new exceptions to accommodate financial arrangements with physicians that involve risk-sharing and gainsharing; (3) granting CMS express authority to create broader waivers, exceptions and advisory opinions than it is currently authorized by law; (4) creation of a new statutory exception for APMs or the creation of a new exception that is modeled on or expands the current Stark Law exception for referrals for services to Medicare prepaid plan enrollees; (5) expansion of the regulatory risk-sharing exception at 42 C.F.R. § 411.357(n) to apply to Medicare and Medicaid FFS programs or creation of a new broader risk-sharing exception; (6) synchronization of the Stark Law with the Civil Monetary Penalties (CMP) law, as amended by MACRA, to clearly accommodate properly structured gainsharing arrangements; (7) expanding CMS's special "volume or value" rule permitting unit-based compensation to permit percentage of savings payments to physicians, and create a presumption that such compensation is fair market value.

Distinguishing Technical Violations and Determining Penalties

The Committee noted that the commenters generally agreed that "technical" violations of the Stark Law should be subject to a separate set of sanctions that would not give rise to either FCA exposure or "potentially ruinous" repayment liability. Certain commenters noted that Congress already recognized the disparity between technical and substantive violations when it created the Self-Referral Disclosure Protocol (SRDP), and recommended that technical violations be addressed with civil monetary penalties. Written comments addressed how technical violations could be distinguished from substantive violations, the need for redefinition of certain key terms to clarify current exceptions and factors for determining a penalty for technical noncompliance.

Written comments suggested that technical violations of the Stark Law could be distinguished from substantive violations by the one of the following approaches: (1) treating violations involving the form of an arrangement, such as the failure to satisfy the signed writing requirement of many Stark exceptions, as technical violations; (2) treating the failure to satisfy the fair market value, "volume or value," and/or commercial reasonableness prongs of an exception as substantive violations; (3) only treating compensation arrangements that violate the federal anti-kickback statute as substantive violations; and (4) creating bright line requirements that would improve clarity and establish the baseline for compliant conduct and treat noncompliance with the bright line requirements as substantive violations. One recommendation was to create an exception for technical noncompliance "based on the regulatory exception for certain arrangements involving temporary noncompliance at 42 C.F.R. § 411.353(f), but with fewer restrictions." Finally, commenters called for clarification of the definitions of key terms, i.e., fair market value, "takes into account" the "volume or value" of referrals, and commercially reasonable.

Other comments recommended the consideration of mitigating factors when determining the penalties associated with technical violations, giving the Secretary of HHS the authority to reduce penalties based on one or more of the following:

(1) whether the violation is technical or substantive; (2) whether the parties' failure to meet all of the prescribed criteria of an applicable exception was due to an innocent or unintentional mistake; (3) the corrective action taken by the parties; (4) whether the services provided were reasonable and medically necessary; (5) whether access to a physician's services was required in an emergency situation; and (6) whether the Medicare program suffered any harm beyond the statutory disallowance.

Other Considerations

The white paper also summarizes a handful of other frustrations with the Stark Law and suggestions for addressing them. These include: (1) aligning the Stark Law's exceptions with the federal anti-kickback statute safe harbors; (2) creating a special compensation exception for tax-exempt entities in recognition that their compensation arrangements are already regulated by the Internal Revenue Service; (3) reversing the Stark Law burdens of proof, creating a presumption that compensation arrangements with referring physicians are fair market value, not determined in a manner that takes into account the volume or value referrals, and on commercially reasonable terms; and (4) streamlining and simplification of the Stark Law's key define terms and its exceptions.

* * *

Senator Hatch announced shortly after publication of the white paper that the Committee would hold a hearing to "examine ways to improve and reform the Stark Law." That hearing was held on July 12, 2016. McDermott will continue to follow these Stark Law reform developments, and report on them in future communications.

Roundtable Discussion Results In Senate Committee White Paper On Stark Law Reform

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.